Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look ...

The Hawkeye star died momentarily when he was crushed under a snowplough - and he says he did not want to return ...

Eli Lilly found itself in a pharmaceutical pickle after its CFO claimed telehealth partners don’t compound key weight-loss ...

HWM surges on aerospace demand, rising earnings, and upgraded guidance, while SQM stumbles on weak results and estimate cuts.

Hims & Hers' 38.4% subscriber growth and $576.4 million online revenues highlight the power of its personalized subscription model.

Eli Lilly will partner only with telehealth firms that agree to stop selling compound versions of its drug Zepbound or Novo Nordisk’s Wegovy, a move that sidelines Hims & Hers Health, Bloomberg ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

U.S. equities gained at midday on better-than-expected consumer inflation news and a trade agreement between the U.S. and ...

Whether you want a medicated solution or an all-natural fix, these pro-backed recommendations can start helping in as little ...

Officials at the FDA say they want to speed up approvals for new drugs and devices using tech like the new "Elsa" AI system. More news is on other uses of AI in health care, Eli Lilly refusing to work ...